MedTrace Logo

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

NCT04535843 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-05-28

No results posted yet for this study

Summary

The present study is a prospective cohort study aiming to improve the clinical capacity in the diagnosis and natural history of Chinese patients with myasthenia gravis (MG). 300 MG patients are planned to recruit, document and prospectively follow up. Management of screening test and cohort manifestation are studied.

Conditions

Interventions

OTHER

Biomarkers and omics data

To detect disease-related biomarkers and omics data, in this prospective MG cohort.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Chongbo Zhao, MD · Huashan Hospital, Shanghai,China

Eligibility

Min Age
0 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2028-02-01
Completion
2028-05-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04535843 on ClinicalTrials.gov